Effects of dibutyryl cyclic AMP and papaverine on intrahepatocytic bile acid transport. Role of vesicle transport. 1993

M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
First Dept. of Internal Medicine, Nagoya City University Medical School, Japan.

The secondary messenger cyclic AMP plays an important role in regulating biliary excretory function by stimulating the transcytotic vesicle transport system, whereas papaverine exerts an inhibitory effect on this system. We therefore investigated their effects on bile acid-induced cytotoxicity and intrahepatocytic content of bile acid in primary cultured rat hepatocytes. Simultaneous addition of 1 mM dibutyryl cyclic AMP (DBcAMP), an analogue of cAMP, with 1 mM taurochenodeoxycholic acid (TCDCA) significantly decreased the release of lactate dehydrogenase (LDH) as compared with the case with 1 mM TCDCA alone (7.1 +/- 0.13% of total versus 10.7 +/- 0.3%). In contrast, 0.1 mM papaverine approximately doubled the amount of LDH (22.0 +/- 0.6% of total versus 10.7 +/- 0.3%; P < 0.01). The intracellular content of TCDCA 180 min after the administration of 1 mM TCDCA alone was 20.8 +/- 0.7 nmol/mg protein, that after simultaneous administration of 1 mM DBcAMP, 16.2 +/- 1.0 nmol/mg protein, and that after the simultaneous administration of 0.1 mM papaverine, 38.5 +/- 1.9 nmol/mg protein. A clear correlation between the release of LDH from hepatocytes and the intracellular content of TCDCA was thus observed. When given together with 1 mM taurocholic acid (TCA) or 1 mM tauroursodeoxycholic acid (TUDCA), papaverine exerted little effect on cytotoxicity or intrahepatocytic bile acid content. When cells were bathed in a medium free of bile acid after pretreatment with 1 mM TCDCA and 1 mM DBcAMP, additional exposure to DBcAMP for 30 min significantly stimulated reduction of intracellular TCDCA content (30.2 +/- 0.4% of total versus 44.0 +/- 1.4%).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010208 Papaverine An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. Cerespan,Papaverine Hydrochloride,Pavabid,Pavatym,Hydrochloride, Papaverine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003994 Bucladesine A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) Dibutyryl Adenosine-3',5'-Monophosphate,Dibutyryl Cyclic AMP,(But)(2) cAMP,Bucladesine, Barium (1:1) Salt,Bucladesine, Disodium Salt,Bucladesine, Monosodium Salt,Bucladesine, Sodium Salt,DBcAMP,Dibutyryl Adenosine 3,5 Monophosphate,N',O'-Dibutyryl-cAMP,N(6),0(2')-Dibutyryl Cyclic AMP,AMP, Dibutyryl Cyclic,Adenosine-3',5'-Monophosphate, Dibutyryl,Cyclic AMP, Dibutyryl,Dibutyryl Adenosine 3',5' Monophosphate,Disodium Salt Bucladesine,Monosodium Salt Bucladesine,N',O' Dibutyryl cAMP,Sodium Salt Bucladesine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D013655 Taurochenodeoxycholic Acid A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic. Chenodeoxycholyltaurine,Taurine Chenodeoxycholate,Taurochenodeoxycholate,Acid, Taurochenodeoxycholic,Chenodeoxycholate, Taurine
D013656 Taurocholic Acid The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic. Cholyltaurine,Taurine Cholate,Taurocholate,Sodium Taurocholate,Taurocholate Sodium,Taurocholic Acid, (5 alpha)-Isomer,Taurocholic Acid, (7 beta)-Isomer,Taurocholic Acid, Monolithium Salt,Taurocholic Acid, Monosodium Salt,Taurocholate, Sodium

Related Publications

M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
January 1977, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
November 1970, Research communications in chemical pathology and pharmacology,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
December 1995, Journal of neurochemistry,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
July 1975, The Tohoku journal of experimental medicine,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
November 1983, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
August 1974, Japanese journal of pharmacology,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
September 1982, Journal of reproduction and fertility,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
July 1983, Lipids,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
August 1974, The Tohoku journal of experimental medicine,
M Hoshino, and T Ohiwa, and T Hayakawa, and Y Kamiya, and A Tanaka, and A Hirano, and T Kumai, and K Katagiri, and M Miyaji, and T Takeuchi
October 1974, Acta physiologica Scandinavica,
Copied contents to your clipboard!